Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Adaptation of Clinical Practice Guideline for Colorectal Cancer Screening in People With Average Risk in Isfahan Province Publisher



Tabesh E1 ; Ghassami M2, 4 ; Rezayatmand R3 ; Tahmasebi M4, 5 ; Adibi P1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Isfahan Gastroenterology and Hepatology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Health Management and Economics Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Clinical Research Development Unit, Ayatollah Kashani Hospital, Shahrekord University of Medical Sciences, Shahrekord, Iran
  5. 5. Health Information Technology Research Center, Clinical Informationist Research Group, Isfahan University of Medical Sciences, Isfahan, Iran

Source: International Journal of Preventive Medicine Published:2022


Abstract

Background: Colorectal cancer (CRC) is the third most common cancer among adults in Iran. The aim of colorectal cancer screening is to reduce the cancer burden in the population by diagnosing the disease in its early stages. Methods: We adapted this guideline for the moderate CRC risk population for Isfahan to determine how to screen them and when to start and end the CRC screening. This guideline was developed by clinical appraisal and review of the evidence, available clinical guidelines, and in consultation with members of the Isfahan Chamber of Iranian association of gastroenterology and hepatology. Results: In screening people with average risk for CRC who use personal resources and personally pay all the costs, colonoscopy is recommended as the first choice to be done every 10 years. In case of negative colonoscopy, we recommend FIT test to prevention of interval cancer every 5 years. In screening of people with average risk of CRC, FIT is suggested to be done every 2 years as a first-choice method test for those who use public resources and do not pay for this service personally. In screening individuals with average risk for CRC, g‑FOBT is not recommended as the first method of choice. Repeating positive guaiac test is not recommended and if positive, colonoscopy is suggested. © 2022 International Journal of Preventive Medicine | Published by Wolters Kluwer - Medknow.
Other Related Docs
9. Temporal Trends of Incidence of Colorectal Cancer in Isfahan, Iran, 2000-2011, International Journal of Preventive Medicine (2018)
10. Economic Burden of Colorectal Cancer: A Scoping Review, Journal of Payavard Salamat (2023)
19. Survival of Rectal Cancer in Yazd, Iran, Asian Pacific Journal of Cancer Prevention (2014)
27. Trends in Colorectal Cancer Incidence in Iran, Journal of Mazandaran University of Medical Sciences (2015)
29. Survival Rate of Colorectal Cancer in Iran: A Systematic Review and Meta-Analysis, Asian Pacific Journal of Cancer Prevention (2019)
33. Results of the Program for Prevention and Control of Non-Communicable Diseases in Isfahan, Scientific Journal of Kurdistan University of Medical Sciences (2021)
35. Early Detection of Colorectal Cancer: From Conventional Methods to Novel Biomarkers, Journal of Cancer Research and Clinical Oncology (2016)
37. Effects of Physical Activity on Risk of Colorectal Cancer: A Case-Control Study, International Journal of Preventive Medicine (2016)
47. Familial Colorectal Cancertype X in Central Iran: A New Clinicopathologic Description, International Journal of Hematology-Oncology and Stem Cell Research (2017)